title: Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey.
abstract: To assess changes in infant vaccination coverage in Flanders since 1999, an EPI-survey was performed in 2005. The parents of 1354 children aged 18-24 months were interviewed at home and the vaccination documents were checked. Several factors possibly related to vaccination status were examined with parametric and non-parametric methods. The coverage rate of recommended vaccines, i.e. poliomyelitis, tetanus-diphtheria-pertussis, H. influenzae type b (Hib), hepatitis B, measles-mumps-rubella (MMR) and meningococcal C, reached at least 92.2%, which is a significant rise for MMR, hepatitis B and Hib since 1999. The vaccinating physician, the employment situation of the mother and the family income were significant predictive factors for having received all recommended vaccine doses (complete schedule), also when considering only doses that were according to minimal age and interval criteria (valid schedule).
authors.affiliation: Centre for The Evaluation of Vaccination, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium. heidi.theeten@ua.ac.be
authors.forename: Heidi
authors.initials: H
authors.lastname: Theeten
authors.forename: Niel
authors.initials: N
authors.lastname: Hens
authors.forename: Corinne
authors.initials: C
authors.lastname: Vandermeulen
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Depoorter
authors.forename: Mathieu
authors.initials: M
authors.lastname: Roelants
authors.forename: Marc
authors.initials: M
authors.lastname: Aerts
authors.forename: Karel
authors.initials: K
authors.lastname: Hoppenbrouwers
authors.forename: Pierre
authors.initials: P
authors.lastname: Van Damme
mesh_terms: D001530:Belgium / Q000453:epidemiology; D016000:Cluster Analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D005544:Forecasting; D006801:Humans; D007223:Infant; D008297:Male; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D011159:Population Surveillance; D012307:Risk Factors; D014612:Vaccines / Q000627:therapeutic use
chemical_list: D014612:Vaccines